Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (3 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
1 selected
)
Type
Guidance (59)
Guidance programme
(
1 selected
)
Guidance programme
Clinical guidelines (1)
Diagnostics guidance (2)
Health technology evaluations (1)
Interventional procedures guidance (3)
NICE guidelines (1)
Technology appraisal guidance (59)
Apply filters
Showing 51 to 59 of 59
Sort by
Date
Title
Apply sorting
lung cancer
Remove lung cancer filter
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell
lung cancer
TA347
22 July 2015
22 July 2015
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell
lung cancer
TA310
23 April 2014
23 April 2014
Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell
lung cancer
TA258
27 June 2012
27 June 2012
Erlotinib monotherapy for maintenance treatment of non-small-cell
lung cancer
TA227
29 June 2011
29 June 2011
Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell
lung cancer
TA192
28 July 2010
28 July 2010
Topotecan for the treatment of relapsed small-cell
lung cancer
TA184
25 November 2009
25 November 2009
Pemetrexed for the first-line treatment of non-small-cell
lung cancer
TA181
23 September 2009
23 September 2009
Bevacizumab for the treatment of non-small-cell
lung cancer
(terminated appraisal)
TA148
25 June 2008
25 June 2008
Pemetrexed for the treatment of non-small-cell
lung cancer
TA124
22 August 2007
22 August 2007
Previous page
1
4
5
Current page
6
Page
6
of
6
Results per page
10
25
50
All
Back to top